Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

Background Advance care planning (ACP) supports patients in identifying and documenting
their preferences and timely discussing them with their relatives and healthcare …

Background & Aims People with cirrhosis have unmet needs, which could benefit from a
palliative care approach. Develo** effective services needs to be based on evidence from …

Background Breathlessness is the most common and intrusive symptom of advanced non-
malignant respiratory and cardiac conditions. The Breathlessness Intervention Service (BIS) …

Background: While there have been some studies looking at the impact on quality of life of
patients with idiopathic pulmonary fibrosis, to date no qualitative research looking at the …

Background Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the
European Medicines Agency and the US Food and Drug Administration for the treatment of …

Background Those affected by advanced fibrotic interstitial lung diseases (ILDs) have
considerable unmet symptom and psychological needs. Case conferencing has been …

Rationale Advanced fibrosing interstitial lung disease (ILD) is often progressive and
associated with a high burden of symptoms and poor prognosis. Little is known about the …

Background People with pulmonary fibrosis often experience a protracted time to diagnosis,
high symptom burden and limited disease information. This review aimed to identify the …

Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive and ultimately fatal lung
disease. The combination of poor prognosis, uncertainty of disease course and severe …